| 1 |
Suzuki S, Eastwood GM, Peck L, et al. Current oxygen management in mechanically ventilated patients: a prospective observational cohort study [J]. J Crit Care, 2013, 28(5): 647-654.
|
| 2 |
Vincent JL, Taccone FS, He X. Harmful effects of hyperoxia in postcardiac arrest, sepsis, traumatic brain injury, or stroke: The importance of individualized oxygen therapy in critically ill patients [J]. Can Respir J, 2017, 2017: 2834956.
|
| 3 |
Helmerhorst HJ, Arts DL, Schultz MJ, et al. Metrics of arterial hyperoxia and associated outcomes in critical care [J]. Crit Care Med, 2017, 45(2): 187-195.
|
| 4 |
Hafner S, Beloncle F, Koch A, et al. Hyperoxia in intensive care, emergency, and peri-operative medicine: Dr. Jekyll or Mr. Hyde? A 2015 update [J]. Ann Intensive Care, 2015, 5(1): 42.
|
| 5 |
Kaydu A, Orhun G, Çakar N. Relationship between arterial oxygen tension and mortality of patients in intensive care unit on mechanical ventilation support [J]. Ulus Travma Acil Cerrahi Derg, 2019, 25(4): 331-337.
|
| 6 |
Bellomo R, Bailey M, Eastwood GM, et al. Study of oxygen in critical care (SOCC) group. arterial hyperoxia and in-hospital mortality after resuscitation from cardiac arrest [J]. Crit Care, 2011, 15(2): R90.
|
| 7 |
Asher SR, Curry P, Sharma D, et al. Survival advantage and PaO2 threshold in severe traumatic brain injury [J]. J Neurosurg Anesthesiol, 2013, 25(2): 168-173.
|
| 8 |
Eastwood G, Bellomo R, Bailey M, et al. Arterial oxygen tension and mortality in mechanically ventilated patients [J]. Intensive Care Med, 2012, 38(1): 91-98.
|
| 9 |
Helmerhorst HJF, Schouten LRA, Wagenaar GTM, et al. Hyperoxia provokes a time- and dose-dependent inflammatory response in mechanically ventilated mice, irrespective of tidal volumes [J]. Intensive Care Med Exp, 2017, 5(1): 27.
|
| 10 |
Kallet RH. Adjunct therapies during mechanical ventilation: airway clearance techniques, therapeutic aerosols, and gases [J]. Respir Care, 2013, 58(6): 1053-1073.
|
| 11 |
Eastwood G, Bellomo R, Bailey M, et al. Arterial oxygen tension and mortality in mechanically ventilated patients [J]. Intensive Care Med, 2012, 38(1): 91-98.
|
| 12 |
Huang YC, Caminiti SP, Fawcett TA, et al. Natural surfactant and hyperoxic lung injury in primates. I. Physiology and biochemistry [J]. J Appl Physiol (1985), 1994, 76(3): 991-1001.
|
| 13 |
Whiting J, Edriss H, Nugent K. Frequency and etiology of ventilator-associated events in the medical intensive care unit [J]. Am J Med Sci, 2015, 350(6): 453-457.
|
| 14 |
Wang M, Gorasiya S, Antoine DJ, et al. The compromise of macrophage functions by hyperoxia is attenuated by ethacrynic acid via inhibition of NF-κB-mediated release of high-mobility group box-1 [J]. Am J Respir Cell Mol Biol, 2015, 52(2): 171-182.
|
| 15 |
Kikuchi Y, Tateda K, Fuse ET, et al. Hyperoxia exaggerates bacterial dissemination and lethality in Pseudomonas aeruginosa pneumonia [J]. Pulm Pharmacol Ther, 2009, 22(4): 333-339.
|
| 16 |
Tateda K, Deng JC, Moore TA, et al. Hyperoxia mediates acute lung injury and increased lethality in murine Legionella pneumonia: the role of apoptosis [J]. J Immunol, 2003, 170(8): 4209-4216.
|
| 17 |
Entezari M, Weiss DJ, Sitapara R, et al. Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against pseudomonas aeruginosa pneumonia in cystic fibrosis [J]. Mol Med, 2012, 18(1): 477-485.
|
| 18 |
Patel VS, Sitapara RA, Gore A, et al. High mobility group Box-1 mediates hyperoxia-induced impairment of pseudomonas aeruginosa clearance and inflammatory lung injury in mice [J]. Am J Respir Cell Mol Biol, 2013, 48(3): 280-287.
|
| 19 |
Helmerhorst HJF, Arts DL, Schultz MJ, et al. Metrics of arterial hyperoxia and associated outcomes in critical care [J]. Crit Care Med, 2017, 45(2): 187-195.
|
| 20 |
Ludke A, Akolkar G, Ayyappan P, et al. Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C [J]. PLoS One, 2017, 12(7): e0179452.
|
| 21 |
Arita Y, Kazzaz JA, Joseph A, et al. Antioxidants improve antibacterial function in hyperoxia-exposed macrophages [J]. Free Radic Biol Med, 2007, 42(10): 1517-1523.
|
| 22 |
Patel VS, Sampat V, Espey MG, et al. Ascorbic acid attenuates hyperoxia-compromised host defense against pulmonary bacterial infection [J]. Am J Respir Cell Mol Biol, 2016, 55(4): 511-520.
|
| 23 |
Liu D, Wang Y, Li L, et al. Celecoxib protects hyperoxia-induced lung injury via NF-κB and AQP1 [J]. Front Pediatr, 2019, 7(7): 228.
|
| 24 |
Jin C, Jin Z, Zhang Y. Glutamine inhibits the inflammation in preterm rats with lung injury induced by hyperoxia and its mechanism [J]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 2018, 34(12): 1086-1090.
|
| 25 |
Wang Y, Zhu Y, Zhu Y, et al. Regulation of the angiotensin Ⅱ-p22phox-reactive oxygen species signaling pathway, apoptosis and 8-oxoguanine-DNA glycosylase 1 retrieval in hyperoxia-induced lung injury and fibrosis in rats [J]. Exp Ther Med, 2017, 13(6): 3397-3407.
|
| 26 |
Dombrowsky H, Tschernig T, Vieten G, et al. Molecular and functional changes of pulmonary surfactant in response to hyperoxia [J]. Pediatr Pulmonol, 2006, 41(11): 1025-1039.
|
| 27 |
Helmerhorst HJ, Roos-Blom MJ, van Westerloo DJ, et al. Associations of arterial carbon dioxide and arterial oxygen concentrations with hospital mortality after resuscitation from cardiac arrest [J]. Crit Care, 2015, 19(9): 348.
|
| 28 |
Suzuki S, Eastwood GM, Goodwin MD, et al. Atelectasis and mechanical ventilation mode during conservative oxygen therapy: a before-and-after study [J]. J Crit Care, 2015, 30(6): 1232-1237.
|
| 29 |
Helmerhorst HJ, Schultz MJ, van der Voort PH, et al. Effectiveness and clinical outcomes of a two-step implementation of conservative oxygenation targets in critically ill patients: a before and after trial [J]. Crit Care Med, 2016, 44(3): 554-563.
|